Aneugenany chemical or process that, by interacting with the components of the mitotic and meiotic cell division cycle apparatus, leads to aneuploidy in cells or organisms.
Aneuploidyany deviation from the normal diploid (or haploid) number of chromosomes by a single chromosome or more than one, but not by entire set(s) of chromosomes (polyploidy).
Apoptosisprogrammed cell death characterised by a series of steps leading to the disintegration of cells into membrane-bound particles that are then eliminated by phagocytosis or by shedding.
Cell proliferationthe increase in cell number as a result of mitotic cell division.
Centromerethe DNA region of a chromosome where both chromatids are held together and on which both kinetochores are attached side-to-side.
Chemicala substance or a mixture.
Concentrationsrefers to final concentrations of the test chemical in the culture medium.
Clastogenany chemical or event which causes structural chromosomal aberrations in populations of cells or eukaryotic organisms.
Cytokinesisthe process of cell division immediately following mitosis to form two daughter cells, each containing a single nucleus.
Cytokinesis-Block Proliferation index (CBPI)the proportion of second-division cells in the treated population relative to the untreated control (see Appendix 2 for formula).
Cytostasisinhibition of cell growth (see Appendix 2 for formula).
Cytotoxicity
For the assays covered in this test method performed in the presence of cytochalasin B, cytotoxicity is identified as a reduction in cytokinesis-block proliferation index (CBPI) or Replication Index (RI) of the treated cells as compared to the negative control (see paragraph 26 and Appendix 2)
For the assays covered in this test method performed in the absence of cytochalasin B, cytotoxicity is identified as a reduction in relative population doubling (RPD) or relative increase in cell count (RICC) of the treated cells as compared to the negative control (see paragraph 27 and Appendix 2).
Genotoxica general term encompassing all types of DNA or chromosome damage, including breaks, deletions, adducts, nucleotides modifications and linkages, rearrangements, gene mutations, chromosome aberrations, and aneuploidy. Not all types of genotoxic effects result in mutations or stable chromosome damage.
Interphase cellscells not in the mitotic stage.
Kinetochorea protein-containing structure that assembles at the centromere of a chromosome to which spindle fibres associate during cell division, allowing orderly movement of daughter chromosomes to the poles of the daughter cells.
Micronucleismall nuclei, separate from and additional to the main nuclei of cells, produced during telophase of mitosis or meiosis by lagging chromosome fragments or whole chromosomes.
Mitosisdivision of the cell nucleus usually divided into prophase, prometaphase, metaphase, anaphase and telophase.
Mitotic indexthe ratio of cells in metaphase divided by the total number of cells observed in a population of cells; an indication of the degree of cell proliferation of that population.
Mutagenicproduces a heritable change of DNA base-pair sequences(s) in genes or of the structure of chromosomes (chromosome aberrations).
Non-disjunctiofailure of paired chromatids to disjoin and properly segregate to the developing daughter cells, resulting in daughter cells with abnormal numbers of chromosomes.
p53 statusp53 protein is involved in cell cycle regulation, apoptosis and DNA repair. Cells deficient in functional p53 protein, unable to arrest cell cycle or to eliminate damaged cells via apoptosis or other mechanisms (e.g. induction of DNA repair) related to p53 functions in response to DNA damage, should be theoretically more prone to gene mutations or chromosomal aberrations.
Polyploidynumerical chromosome aberrations in cells or organisms involving entire set(s) of chromosomes, as opposed to an individual chromosome or chromosomes (aneuploidy).
Proliferation Index (PI)method for cytotoxicity measurement when cytoB is not used (see Appendix 2 for formula).
Relative Increase in Cell Count (RICC)method for cytotoxicity measurement when cytoB is not used (see Appendix 2 for formula).
Relative Population Doubling (RPD)method for cytotoxicity measurement when cytoB is not used (see Appendix 2 for formula).
Replication Index (RI)the proportion of cell division cycles completed in a treated culture, relative to the untreated control, during the exposure period and recovery (see Appendix 2 for formula).
S9 liver fractionsupernatant of liver homogenate after 9000 g centrifugation, i.e. raw liver extract.
S9 mixmix of the S9 liver fraction and cofactors necessary for metabolic enzyme activity.
Solvent controlGeneral term to define the control cultures receiving the solvent alone used to dissolve the test chemical.
Test chemicalAny substance or mixture tested using this test method.
Untreated controlcultures that receive no treatment (i.e. no test chemical nor solvent) but are processed concurrently in the same way as the cultures receiving the test chemical.